Research Site

Rennaz 1847

1 studies enrolling now · 1 studies all time

What they study most

ER-Positive HER2-Negative Breast Cancer

Studies at this site

• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer — Recruiting now